The BioNTech and Pfizer vaccine could receive the approval of the European Medicines Agency (EMA) on December 23, according to the newspapers published on Tuesday Bild and Frankfurter Allgemeine Zeitung. The Agency is considering this change of date after pressure from several countries and, according to Reuters citing a German government source, from this country they assume that the verdict will be given that day.
A nurse from New York, the first person to receive the coronavirus vaccine authorized in the US
Asked about it at a press conference, the German Minister of Health, Jens Spahn, has assured that it would be “good news” and that he had that date because he had read it in the press, it seemed “plausible” and because it was just before Christmas. Spahn has highlighted the importance of having a European and not a national process in the authorization of the vaccine, since in this way the knowledge and experience of the various responsible agencies in the member countries can be used.
In addition, it allows vaccination to start simultaneously at 27, which increases cohesion within the EU, according to Spahn’s argument.
He Frankfurter Allgemeine Zeitung He clarifies that the EMA only gives the go-ahead, while it is the European Commission who grants the authorization, for which a period of 24 hours has been given. Bild, which cites sources in the European Commission and the German Government, adds that the start of the vaccination campaign in Germany would take place on December 26, although other media advance it to 25.
The expected date was December 29
The European Medicines Agency has not confirmed the advance of the date to 23 – the scheduled day was December 29, and for Moderna it was January 12 – and, according to a spokeswoman to AFP, it has not changed for the moment the stage: “We know the article from Bild. We continue working with the date of 29 at the latest “.
A BioNTech spokeswoman has communicated to Bild that the company has already produced and stored part of the contingent of vaccines that the European Union bought. “As soon as we have the green light from the EMA and the EC, we can begin with the download and distribution of vaccines to the centers,” he indicated.